CA Stock MarketDetailed Quotes

JNH Jack Nathan Medical Corp

Watchlist
  • 0.030
  • 0.0000.00%
15min DelayMarket Closed Nov 14 16:00 ET
2.61MMarket Cap-375P/E (TTM)

Jack Nathan Medical Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Oct 31, 2023
(Q2)Jul 31, 2023
(Q1)Apr 30, 2023
(FY)Jan 31, 2023
(Q4)Jan 31, 2023
(Q3)Oct 31, 2022
(Q2)Jul 31, 2022
(Q1)Apr 30, 2022
(FY)Jan 31, 2022
(Q4)Jan 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-663.86%-1.04M
-756.58%-1.57M
-276.65%-302.26K
54.60%-2M
-110.25%-1.61M
91.64%-135.87K
84.82%-183.85K
90.16%-80.25K
-445.79%-4.42M
-4.76%-763.4K
Net income from continuing operations
-150.71%-2.05M
-10.31%-1.54M
37.66%-789.9K
13.89%-6.9M
-45.40%-3.42M
62.11%-819.18K
26.19%-1.39M
21.41%-1.27M
19.14%-8.02M
-3.83%-2.35M
Depreciation and amortization
-20.07%210.91K
41.17%365.58K
9.64%296.35K
107.38%1.07M
3.27%277.21K
157.34%263.87K
247.75%258.96K
282.30%270.3K
256.35%516.13K
389.21%268.42K
Asset impairment expenditure
----
----
----
46.47%1.41M
----
----
----
----
137.68%960.96K
----
Remuneration paid in stock
-39.28%115.31K
-1.50%166.22K
-53.36%188.86K
-54.93%1.13M
-45.28%363.15K
-71.64%189.89K
-64.74%168.75K
-41.14%404.94K
197.93%2.5M
-6.45%663.66K
Other non cashItems
306.60%109.94K
-1,715.68%-765.56K
91.46%57.77K
66.90%-83.71K
41.90%-188.3K
14.17%27.04K
102.62%47.38K
24.92%30.17K
-103.01%-252.86K
-181.98%-324.08K
Change In working capital
214.69%637.29K
-73.36%195.53K
-111.50%-55.34K
2,924.35%1.38M
-141.92%-41.04K
177.92%202.51K
636.90%734.02K
3,427.55%481.41K
93.61%-48.75K
-75.78%97.9K
-Change in receivables
-427.72%-535.74K
-452.05%-231.71K
-18.17%225.37K
102.35%15.52K
-353.49%-224.18K
52.12%-101.52K
118.28%65.82K
816.09%275.4K
-263.15%-659.87K
-121.42%-49.43K
-Change in prepaid assets
-49.67%-166.58K
-73.81%57.18K
17.93%54.99K
129.70%101.9K
62.71%-51.77K
29.00%-111.29K
187.15%218.33K
137.75%46.63K
-134.08%-343.08K
3.45%-138.83K
-Change in payables and accrued expense
229.87%1.31M
-117.47%-80.22K
-318.16%-343.58K
32.47%1.35M
214.50%334.4K
137.13%397.44K
-4.55%459.09K
-40.12%157.49K
351.84%1.02M
-72.15%106.33K
-Change in other working capital
59.71%28.56K
4,990.03%450.27K
317.06%7.87K
-39.61%-88.93K
-155.33%-99.49K
130.44%17.88K
90.55%-9.21K
102.16%1.89K
-108.67%-63.7K
378.24%179.83K
Cash from discontinued investing activities
Operating cash flow
-663.86%-1.04M
-756.58%-1.57M
-276.65%-302.26K
53.81%-2M
-133.37%-1.61M
91.64%-135.87K
84.82%-183.85K
90.16%-80.25K
-436.45%-4.34M
5.62%-687.77K
Investing cash flow
Cash flow from continuing investing activities
-72.09%-1.12M
-428.36%-900.13K
-23,110.89%-616.02K
-25.52%-2.69M
-123.54%-1.86M
-112.93%-650.64K
51.50%-170.36K
99.59%-2.65K
-746.16%-2.14M
-76.25%-833.07K
Net PPE purchase and sale
-72.09%-1.12M
-428.36%-900.13K
-23,110.89%-616.02K
-171.95%-2.59M
-417.59%-1.76M
-179.08%-650.64K
51.50%-170.36K
89.78%-2.65K
-90.28%-950.9K
27.97%-340.49K
Net business purchase and sale
----
----
----
85.34%-174.3K
----
----
----
----
-581.66%-1.19M
---492.58K
Net other investing changes
----
----
----
--74.41K
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-72.09%-1.12M
-428.36%-900.13K
-23,110.89%-616.02K
-25.52%-2.69M
-123.54%-1.86M
-112.93%-650.64K
51.50%-170.36K
99.59%-2.65K
-746.16%-2.14M
-76.25%-833.07K
Financing cash flow
Cash flow from continuing financing activities
-89.07%208.94K
2,340.77%8.63M
515.88%651.53K
3,309.48%5.28M
2,688.26%3.17M
1,582.79%1.91M
331.32%353.5K
-5,437.65%-156.66K
-101.89%-164.43K
-103.47%-122.41K
Net issuance payments of debt
-106.83%-130.51K
1,314.35%8.57M
298.10%310.34K
1,306.40%3.08M
439.14%720.37K
1,582.53%1.91M
873.66%606K
-100.00%-156.66K
39.04%-255.44K
-162.26%-212.41K
Proceeds from stock option exercised by employees
----
----
----
-181.76%-74.41K
----
----
----
----
-97.92%91.01K
--0
Net other financing activities
113,809.73%339.45K
--57.2K
--341.18K
--2.27M
--2.52M
--298
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-89.07%208.94K
2,340.77%8.63M
515.88%651.53K
3,309.48%5.28M
2,688.26%3.17M
1,582.79%1.91M
331.32%353.5K
-5,437.65%-156.66K
-101.89%-164.43K
-103.47%-122.41K
Net cash flow
Beginning cash position
787.02%7.24M
42.26%1.13M
37.37%1.46M
-86.16%1.06M
-41.57%1.6M
-81.85%816.49K
-87.29%794.82K
-86.16%1.06M
--7.69M
-48.84%2.74M
Current changes in cash
-273.10%-1.95M
861,893.28%6.15M
-11.35%-266.76K
108.83%586.47K
81.81%-298.93K
163.23%1.13M
99.96%-714
83.69%-239.56K
-187.24%-6.64M
-170.59%-1.64M
Effect of exchange rate changes
98.29%-5.78K
-285.48%-41.51K
-116.69%-64.19K
-1,037.66%-188.83K
518.11%156.74K
-1,406.56%-338.32K
--22.38K
-193.36%-29.62K
-72.04%20.14K
-907.44%-37.49K
End cash Position
229.71%5.29M
787.02%7.24M
42.26%1.13M
37.37%1.46M
37.37%1.46M
-41.57%1.6M
-81.85%816.49K
-87.29%794.82K
-86.16%1.06M
-86.16%1.06M
Free cash from
-174.32%-2.16M
-598.72%-2.47M
-1,007.64%-918.28K
13.24%-4.59M
-227.48%-3.37M
57.70%-786.5K
77.33%-354.22K
90.15%-82.9K
-304.28%-5.29M
14.41%-1.03M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Oct 31, 2023(Q2)Jul 31, 2023(Q1)Apr 30, 2023(FY)Jan 31, 2023(Q4)Jan 31, 2023(Q3)Oct 31, 2022(Q2)Jul 31, 2022(Q1)Apr 30, 2022(FY)Jan 31, 2022(Q4)Jan 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -663.86%-1.04M-756.58%-1.57M-276.65%-302.26K54.60%-2M-110.25%-1.61M91.64%-135.87K84.82%-183.85K90.16%-80.25K-445.79%-4.42M-4.76%-763.4K
Net income from continuing operations -150.71%-2.05M-10.31%-1.54M37.66%-789.9K13.89%-6.9M-45.40%-3.42M62.11%-819.18K26.19%-1.39M21.41%-1.27M19.14%-8.02M-3.83%-2.35M
Depreciation and amortization -20.07%210.91K41.17%365.58K9.64%296.35K107.38%1.07M3.27%277.21K157.34%263.87K247.75%258.96K282.30%270.3K256.35%516.13K389.21%268.42K
Asset impairment expenditure ------------46.47%1.41M----------------137.68%960.96K----
Remuneration paid in stock -39.28%115.31K-1.50%166.22K-53.36%188.86K-54.93%1.13M-45.28%363.15K-71.64%189.89K-64.74%168.75K-41.14%404.94K197.93%2.5M-6.45%663.66K
Other non cashItems 306.60%109.94K-1,715.68%-765.56K91.46%57.77K66.90%-83.71K41.90%-188.3K14.17%27.04K102.62%47.38K24.92%30.17K-103.01%-252.86K-181.98%-324.08K
Change In working capital 214.69%637.29K-73.36%195.53K-111.50%-55.34K2,924.35%1.38M-141.92%-41.04K177.92%202.51K636.90%734.02K3,427.55%481.41K93.61%-48.75K-75.78%97.9K
-Change in receivables -427.72%-535.74K-452.05%-231.71K-18.17%225.37K102.35%15.52K-353.49%-224.18K52.12%-101.52K118.28%65.82K816.09%275.4K-263.15%-659.87K-121.42%-49.43K
-Change in prepaid assets -49.67%-166.58K-73.81%57.18K17.93%54.99K129.70%101.9K62.71%-51.77K29.00%-111.29K187.15%218.33K137.75%46.63K-134.08%-343.08K3.45%-138.83K
-Change in payables and accrued expense 229.87%1.31M-117.47%-80.22K-318.16%-343.58K32.47%1.35M214.50%334.4K137.13%397.44K-4.55%459.09K-40.12%157.49K351.84%1.02M-72.15%106.33K
-Change in other working capital 59.71%28.56K4,990.03%450.27K317.06%7.87K-39.61%-88.93K-155.33%-99.49K130.44%17.88K90.55%-9.21K102.16%1.89K-108.67%-63.7K378.24%179.83K
Cash from discontinued investing activities
Operating cash flow -663.86%-1.04M-756.58%-1.57M-276.65%-302.26K53.81%-2M-133.37%-1.61M91.64%-135.87K84.82%-183.85K90.16%-80.25K-436.45%-4.34M5.62%-687.77K
Investing cash flow
Cash flow from continuing investing activities -72.09%-1.12M-428.36%-900.13K-23,110.89%-616.02K-25.52%-2.69M-123.54%-1.86M-112.93%-650.64K51.50%-170.36K99.59%-2.65K-746.16%-2.14M-76.25%-833.07K
Net PPE purchase and sale -72.09%-1.12M-428.36%-900.13K-23,110.89%-616.02K-171.95%-2.59M-417.59%-1.76M-179.08%-650.64K51.50%-170.36K89.78%-2.65K-90.28%-950.9K27.97%-340.49K
Net business purchase and sale ------------85.34%-174.3K-----------------581.66%-1.19M---492.58K
Net other investing changes --------------74.41K------------------------
Cash from discontinued investing activities
Investing cash flow -72.09%-1.12M-428.36%-900.13K-23,110.89%-616.02K-25.52%-2.69M-123.54%-1.86M-112.93%-650.64K51.50%-170.36K99.59%-2.65K-746.16%-2.14M-76.25%-833.07K
Financing cash flow
Cash flow from continuing financing activities -89.07%208.94K2,340.77%8.63M515.88%651.53K3,309.48%5.28M2,688.26%3.17M1,582.79%1.91M331.32%353.5K-5,437.65%-156.66K-101.89%-164.43K-103.47%-122.41K
Net issuance payments of debt -106.83%-130.51K1,314.35%8.57M298.10%310.34K1,306.40%3.08M439.14%720.37K1,582.53%1.91M873.66%606K-100.00%-156.66K39.04%-255.44K-162.26%-212.41K
Proceeds from stock option exercised by employees -------------181.76%-74.41K-----------------97.92%91.01K--0
Net other financing activities 113,809.73%339.45K--57.2K--341.18K--2.27M--2.52M--298----------------
Cash from discontinued financing activities
Financing cash flow -89.07%208.94K2,340.77%8.63M515.88%651.53K3,309.48%5.28M2,688.26%3.17M1,582.79%1.91M331.32%353.5K-5,437.65%-156.66K-101.89%-164.43K-103.47%-122.41K
Net cash flow
Beginning cash position 787.02%7.24M42.26%1.13M37.37%1.46M-86.16%1.06M-41.57%1.6M-81.85%816.49K-87.29%794.82K-86.16%1.06M--7.69M-48.84%2.74M
Current changes in cash -273.10%-1.95M861,893.28%6.15M-11.35%-266.76K108.83%586.47K81.81%-298.93K163.23%1.13M99.96%-71483.69%-239.56K-187.24%-6.64M-170.59%-1.64M
Effect of exchange rate changes 98.29%-5.78K-285.48%-41.51K-116.69%-64.19K-1,037.66%-188.83K518.11%156.74K-1,406.56%-338.32K--22.38K-193.36%-29.62K-72.04%20.14K-907.44%-37.49K
End cash Position 229.71%5.29M787.02%7.24M42.26%1.13M37.37%1.46M37.37%1.46M-41.57%1.6M-81.85%816.49K-87.29%794.82K-86.16%1.06M-86.16%1.06M
Free cash from -174.32%-2.16M-598.72%-2.47M-1,007.64%-918.28K13.24%-4.59M-227.48%-3.37M57.70%-786.5K77.33%-354.22K90.15%-82.9K-304.28%-5.29M14.41%-1.03M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data